Revision Date | 2022-07-19 |
1. Disclosure Documents in relation with Revision | Decision on Acquisition of Tangible Assets | |
2. Submission date of documents | 2022-05-20 | |
3. Reason for Revision | Conclusion of a land sales contract | |
4. Revised Information | ||
information | before revision | after revision |
2. Details of acquisition - Acquisition price (KRW) | 426,022,798,554 | 426,021,964,070 |
5. Scheduled acquisition date | 2025-04-30 | 2025-07-18 |
7. Other important matters related to investment judgment |
- The above case is for the purchase of a site for the 2nd Bio Campus, and we have been selected as the preferred bidder and are in the process of negotiating to conclude a land sale contract. - The above '5. Scheduled Acquisition Date'is after the purchase price is paid in full, and as the preferential negotiation period related to the land sales contract is extended, a disclosure of correction will be made at the time the contract is concluded. |
- The above case concerns the purchase of a site for the 2nd Bio Campus, and the Company concluded the land sales contract on July 18th, 2022. - The '5. Scheduled acquisition date' above is the expected date of full payment of the transaction price. |
- |
1. Type of asset to be acquired | Land & buildings | |
- Name of asset to be acquired |
Songdo International City High-tech Industrial Cluster (C) Ki19 (430 Songdo-dong, Yeonsu-gu, Incheon) | |
2. Details of acquisition | Acquisition price (KRW) | 426,021,964,070 |
Total assets (KRW) | 7,970,010,786,863 | |
Ratio to total assets (%) | 5.35 | |
Classified as a large-sized corporation? | Yes | |
3. Counterparty | Incheon Free Economic Zone Authority (IFEZ) | |
4. Purpose of acquisition | 2nd BIO Campus site purchase | |
5. Scheduled acquisition date | 2025-07-18 | |
6. Date of board resolution (decision date) | 2022-03-29 | |
- Attendance of outside directors | Present (No.) | 4 |
Absent (No.) | - | |
- Attendance of auditors (members of Audit Committee who are not outside directors) | - | |
7. Other matters to be factored into investment decisions | ||
- The above case concerns the purchase of a site for the 2nd Bio Campus, and the Company concluded the land sales contract on July 18th, 2022. - The above total assets under 'Details of acquisition' are based on the consolidated financial statements as of the end of 2021. - The '5. Scheduled acquisition date' above is the expected date of full payment of the transaction price. - Details such as acquisition amount and scheduled acquisition date are subject to change later. | ||
※ Related disclosure | - |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Samsung Biologics Co. Ltd. published this content on 19 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 July 2022 07:03:00 UTC.